Ranitidine in acute upper gastrointestinal haemorrhage.
作者信息
Dawson J, Cockel R
出版信息
Br Med J (Clin Res Ed). 1982 Aug 14;285(6340):476-7. doi: 10.1136/bmj.285.6340.476.
Abstract
摘要
相似文献
1
Ranitidine in acute upper gastrointestinal haemorrhage.
Br Med J (Clin Res Ed). 1982 Aug 14;285(6340):476-7. doi: 10.1136/bmj.285.6340.476.
2
Ranitidine in acute upper gastrointestinal haemorrhage.
Br Med J (Clin Res Ed). 1982 Nov 27;285(6354):1575-6. doi: 10.1136/bmj.285.6354.1575-b.
3
Ranitidine in the treatment of acute upper gastrointestinal haemorrhage--a comparative study. Preliminary report.
Hepatogastroenterology. 1981 Oct;28(5):267-9.
4
Ranitidine, reflux, and oesophageal motility.
Lancet. 1983 Mar 26;1(8326 Pt 1):705-6. doi: 10.1016/s0140-6736(83)91993-1.
5
Ranitidine in the prevention of gastric and duodenal ulcer relapse.
Gut. 1983 May;24(5):418-20. doi: 10.1136/gut.24.5.418.
6
Ranitidine in insulin-dependent diabetes.
Lancet. 1982 Oct 16;2(8303):883-4. doi: 10.1016/s0140-6736(82)90854-6.
7
Ranitidine in acute upper gastrointestinal haemorrhage.
Br Med J (Clin Res Ed). 1982 Nov 13;285(6352):1423. doi: 10.1136/bmj.285.6352.1423.
8
New drugs. H2 receptor antagonists--cimetidine and ranitidine.
Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):695-7. doi: 10.1136/bmj.286.6366.695.
9
Ranitidine heals duodenal ulcers.
S Afr Med J. 1982 Jan 30;61(5):152-4.
10
Ranitidine in long-term duodenal ulcer treatment: a multicentre trial.
Digestion. 1982;24(4):260-3. doi: 10.1159/000198806.
引用本文的文献
1
Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
Drugs. 1994 Jun;47(6):862-71. doi: 10.2165/00003495-199447060-00002.
2
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
Drugs. 1982 Oct;24(4):267-303. doi: 10.2165/00003495-198224040-00002.
3
Pharmacokinetics of ranitidine in acute upper gastrointestinal haemorrhage.
Br J Clin Pharmacol. 1985 Dec;20(6):699-702. doi: 10.1111/j.1365-2125.1985.tb05133.x.
4
Why have controlled trials failed to demonstrate a benefit of esophagogastroduodenoscopy in acute upper gastrointestinal bleeding? A probability model analysis.
Dig Dis Sci. 1986 Jul;31(7):760-8. doi: 10.1007/BF01296455.
5
Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.
Gut. 1988 Apr;29(4):453-7. doi: 10.1136/gut.29.4.453.
6
Upper gastrointestinal bleeding: the trials of trials.
Gut. 1985 Mar;26(3):217-20. doi: 10.1136/gut.26.3.217.
本文引用的文献
1
Hematemesis and melena; with special reference to causation and to the factors influencing the mortality from bleeding peptic ulcers.
Gastroenterology. 1956 Feb;30(2):166-90.
2
Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
Gastroenterology. 1980 Dec;79(6):1267-71.
3
A study of the factors influencing mortality rates from gastrointestinal haemorrhage.
Q J Med. 1976 Oct;45(180):533-50.
4
Controlled trial of cimetidine in upper gastrointestinal haemorrhage.
Gut. 1979 Oct;20(10):892-5. doi: 10.1136/gut.20.10.892.
5
H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials.
Lancet. 1977 Mar 19;1(8012):617-9. doi: 10.1016/s0140-6736(77)92055-4.
Zotero 插件